“Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Naïve and Switched Patients: After 5 Years of Follow-Up”. Journal of Pharmacy and Nutrition Sciences 12 (December 13, 2022): 74–79. Accessed May 19, 2026. https://setpublisher.com/index.php/jpans/article/view/2440.